These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36804850)

  • 21. Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease.
    Heaven MR; Wilson L; Barnes S; Brenner M
    J Biol Chem; 2019 Oct; 294(43):15604-15612. PubMed ID: 31484723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic care of late-onset Alexander disease presenting with area postrema-like syndrome with prednisolone; a case report.
    Zardadi S; Razmara E; Rasoulinezhad M; Babaei M; Ashrafi MR; Pak N; Garshasbi M; Tavasoli AR
    BMC Pediatr; 2022 Jul; 22(1):412. PubMed ID: 35831840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A report of two cases of bulbospinal form Alexander disease and preliminary exploration of the disease.
    Song X; Jiang J; Tian W; Zhan F; Zhu Z; Li B; Tang H; Cao L
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of Alexander disease with dropped head syndrome].
    Maeda K; Iwai K; Kobayashi Y; Tsuji H; Yoshida T; Kobayashi Y
    Rinsho Shinkeigaku; 2018 Mar; 58(3):198-201. PubMed ID: 29491332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggregate formation analysis of GFAP
    Tulyeu J; Tamaura M; Jimbo E; Shimbo H; Takano K; Iai M; Yamashita S; Goto T; Aida N; Tokuhiro E; Yamagata T; Osaka H
    Brain Dev; 2019 Feb; 41(2):195-200. PubMed ID: 30213442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult Alexander disease with autosomal dominant transmission: a distinct entity caused by mutation in the glial fibrillary acid protein gene.
    Stumpf E; Masson H; Duquette A; Berthelet F; McNabb J; Lortie A; Lesage J; Montplaisir J; Brais B; Cossette P
    Arch Neurol; 2003 Sep; 60(9):1307-12. PubMed ID: 12975300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel nonsense mutation in the rod domain of GFAP that is associated with Alexander disease.
    Nam TS; Kim JH; Chang CH; Yoon W; Jung YS; Kang SY; Shin BA; Perng MD; Choi SY; Kim MK
    Eur J Hum Genet; 2015 Jan; 23(1):72-8. PubMed ID: 24755947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of severe Alexander disease with de novo c. 239 T > C, p.(F80S), in GFAP.
    Matsumoto A; Tulyeu J; Furukawa R; Watanabe C; Monden Y; Nozaki Y; Mori M; Namekawa M; Jimbo EF; Aihara T; Yamagata T; Osaka H
    Brain Dev; 2018 Aug; 40(7):587-591. PubMed ID: 29573842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel in-frame GFAP p.E138_L148del mutation in Type II Alexander disease with atypical phenotypes.
    Kang YR; Lee SH; Lin NH; Lee SJ; Yang AW; Chandrasekaran G; Kang KW; Jin MS; Kim MK; Perng MD; Choi SY; Nam TS
    Eur J Hum Genet; 2022 Jun; 30(6):687-694. PubMed ID: 35246666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An unusual presentation of late-onset Alexander's disease with slow orthostatic tremor and a novel GFAP variant.
    Stitt DW; Gavrilova R; Watson R; Hassan A
    Neurocase; 2018; 24(5-6):266-268. PubMed ID: 30755139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease.
    Tian R; Gregor M; Wiche G; Goldman JE
    Am J Pathol; 2006 Mar; 168(3):888-97. PubMed ID: 16507904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mutation in the
    Casasnovas C; Verdura E; Vélez V; Schlüter A; Pons-Escoda A; Homedes C; Ruiz M; Fourcade S; Launay N; Pujol A
    J Med Genet; 2019 Dec; 56(12):846-849. PubMed ID: 31004048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukodystrophy with Macrocephaly, Refractory Epilepsy, and Severe Hyponatremia-The Neonatal Type of Alexander Disease.
    Paprocka J; Nowak M; Machnikowska-Sokołowska M; Rutkowska K; Płoski R
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alexander disease: a leukodystrophy caused by a mutation in GFAP.
    Johnson AB
    Neurochem Res; 2004 May; 29(5):961-4. PubMed ID: 15139294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alexander disease: diversity of cell population and interactions between neuron and glia].
    Saito K; Shigetomi E; Koizumi S
    Nihon Yakurigaku Zasshi; 2021; 156(4):239-243. PubMed ID: 34193704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease.
    Hagemann TL; Boelens WC; Wawrousek EF; Messing A
    Hum Mol Genet; 2009 Apr; 18(7):1190-9. PubMed ID: 19129171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes.
    Boyd MM; Litscher SJ; Seitz LL; Messing A; Hagemann TL; Collier LS
    J Neuroinflammation; 2021 Mar; 18(1):67. PubMed ID: 33685480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial adult-onset Alexander disease with a novel mutation (D78N) in the glial fibrillary acidic protein gene with unusual bilateral basal ganglia involvement.
    Wada Y; Yanagihara C; Nishimura Y; Namekawa M
    J Neurol Sci; 2013 Aug; 331(1-2):161-4. PubMed ID: 23743246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Mutation of
    Ciammola A; Sangalli D; Sassone J; Poletti B; Carelli L; Banfi P; Pappacoda G; Ceccherini I; Grossi A; Maderna L; Pingue M; Girotti F; Silani V
    Front Neurol; 2019; 10():1124. PubMed ID: 31781017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GFAP expression as an indicator of disease severity in mouse models of Alexander disease.
    Jany PL; Hagemann TL; Messing A
    ASN Neuro; 2013; 5(1):e00109. PubMed ID: 23432455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.